Pentacycloundecane-diol-Based HIV-1 Protease Inhibitors: Biological Screening, 2D NMR, and Molecular Simulation Studies

Pentacycloundecane-based inhibitors of wild-type C-South African HIV-protease

(2011) Maya M. Makatini et al.   BIOORGANIC & MEDICINAL CHEMISTRY LETTERS

Pentacycloundecane derived hydroxy acid peptides: A new class of irreversible non-scissile ether bridged type isoster as potential HIV-1 wild type C-SA protease inhibitors

(2011) Rajshekhar Karpoormath et al.   BIOORGANIC CHEMISTRY

Synthesis and structural studies of pentacycloundecane-based HIV-1 PR inhibitors: A hybrid 2D NMR and docking/QM/MM/MD approach

(2011) Maya M. Makatini et al.   EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

N,N′-[(8-endo,11-endo-Dihydroxypentacyclo[5.4.0.02,6.03,10.05,9]undecane-8,11-diyl)bis(methylenecarbonyl)]di-L-phenylalanine

(2010) Rajshekhar Karpoormath et al.   ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE

Synthesis and evaluation of SQ109 analogues as potential anti-tuberculosis candidates

(2010) Oluseye K. Onajole et al.   EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

EASY ROESY: Reliable Cross-Peak Integration in Adiabatic Symmetrized ROESY

(2008) Christina M. Thiele et al.   CHEMISTRY-A EUROPEAN JOURNAL

Active-Site Mutations in the South African Human Immunodeficiency Virus Type 1 Subtype C Protease Have a Significant Impact on Clinical Inhibitor Binding: Kinetic and Thermodynamic Study

(2008) S. Mosebi et al.   JOURNAL OF VIROLOGY